These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1005563)

  • 1. The coincidence of schizophrenia and Parkinsonism: some neurochemical implications.
    Crow TJ; Johnstone EC; McClelleand HA
    Psychol Med; 1976 May; 6(2):227-33. PubMed ID: 1005563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cigarette smoking and neuroleptic-induced parkinsonism.
    Decina P; Caracci G; Sandik R; Berman W; Mukherjee S; Scapicchio P
    Biol Psychiatry; 1990 Sep; 28(6):502-8. PubMed ID: 1977478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical and neural mechanisms of positive and negative symptoms in schizophrenia.
    Pickar D; Litman RE; Konicki PE; Wolkowitz OM; Breier A
    Mod Probl Pharmacopsychiatry; 1990; 24():124-51. PubMed ID: 1970851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine and schizophrenia.
    Crow TJ; Johnstone EC; Deakin JF; Longden A
    Lancet; 1976 Sep; 2(7985):563-6. PubMed ID: 60635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond the dopamine hypothesis to the NMDA glutamate receptor hypofunction hypothesis of schizophrenia.
    Stahl SM
    CNS Spectr; 2007 Apr; 12(4):265-8. PubMed ID: 17426663
    [No Abstract]   [Full Text] [Related]  

  • 6. Automimmune response to dopamine-receptor as a possible mechanism in the pathogenesis of Parkinson's disease and schizophrenia.
    Abramsky O; Litvin Y
    Perspect Biol Med; 1978; 22(1):104-14. PubMed ID: 733451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do we still believe in the dopamine hypothesis? New data bring new evidence.
    Abi-Dargham A
    Int J Neuropsychopharmacol; 2004 Mar; 7 Suppl 1():S1-5. PubMed ID: 14972078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nucleus accumbens--possible site of antipsychotic action of neuroleptic drugs?
    Crow TJ; Deakin JF; Longden A
    Psychol Med; 1977 May; 7(2):213-21. PubMed ID: 560024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine, the prefrontal cortex and schizophrenia.
    Knable MB; Weinberger DR
    J Psychopharmacol; 1997; 11(2):123-31. PubMed ID: 9208376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A theoretical and neurophysiological consideration on the pathogenesis of positive symptoms of schizophrenia: implications of dopaminergic function in the emotional circuit.
    Maeda H
    Jpn J Psychiatry Neurol; 1994 Mar; 48(1):99-110. PubMed ID: 7933723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major psychosis and dopamine: controversial features and some suggestions.
    Miller R
    Psychol Med; 1984 Nov; 14(4):779-89. PubMed ID: 6152742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuropathology of schizophrenia.
    Bachus SE; Kleinman JE
    J Clin Psychiatry; 1996; 57 Suppl 11():72-83. PubMed ID: 8941174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroleptics and nicotine].
    Erdmann R
    Psychiatr Prax; 1995 Nov; 22(6):223-7. PubMed ID: 8570751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine excretion and vulnerability to drug-induced Parkinsonism. Schizophrenic patients.
    Crowley TJ; Hoehn MM; Rutledge CO; Stallings MA; Heaton RK; Sundell S; Stilson D
    Arch Gen Psychiatry; 1978 Jan; 35(1):97-104. PubMed ID: 619844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptors and the dopamine hypothesis of schizophrenia.
    Seeman P
    Synapse; 1987; 1(2):133-52. PubMed ID: 2905529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional alpha-synuclein aggregation, dopaminergic dysregulation, and the development of drug-related visual hallucinations in Parkinson's disease.
    Papapetropoulos S
    J Neuropsychiatry Clin Neurosci; 2006; 18(2):149-57. PubMed ID: 16720791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dreaming and schizophrenia: a common neurobiological background?].
    Gottesmann C
    Med Sci (Paris); 2006 Feb; 22(2):201-5. PubMed ID: 16457764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia.
    Kapur S
    Am J Psychiatry; 2003 Jan; 160(1):13-23. PubMed ID: 12505794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinsonism in neuroleptic-naive schizophrenic patients.
    Caligiuri MP; Lohr JB; Jeste DV
    Am J Psychiatry; 1993 Sep; 150(9):1343-8. PubMed ID: 8352344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a right hemi-hyper-dopaminergic psychosis?
    Bracha HS
    Schizophr Res; 1989; 2(4-5):317-24. PubMed ID: 2487172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.